The American Academy of Orthopaedic Surgeons (AAOS) continues to demonstrate its commitment to advancing the quality of musculoskeletal care in a fully transparent and scientific way. Debuting today as a new member benefit, the AAOS Biologics Dashboard is a dynamic online tool designed to help orthopaedic surgeons navigate the approval status of biologic-based interventions. The development of the AAOS Biologics Dashboard is just one of several efforts within the Academy’s Biologics Initiative that offers evidence-based guidance to the musculoskeletal health community. An additional effort is the revision of two biologics-related position statements, recently approved by the AAOS Board of Directors.
Athletes commonly experience pain in practice and competition. Inadequate or inappropriate pain management in adolescent athletes can lead to a lifetime of consequences including increased risk of opioid misuse. A team physician consensus statement just released by ACSM and 5 other sports medicine organizations shares guidelines to identify and manage pain in athletes ages 10 to 18.
New information from NCCN, ASCO, ASH, CDC, FDA, and others seeks to provide clear guidance on how to optimally manage cancer-related pain without exacerbating the ongoing opioid crisis—published jointly in the Journal of the National Comprehensive Cancer Network and JCO Oncology Practice.
A reduction in suicides among patients at a Veterans Health Administration (VHA) facility may be due to a multispecialty opioid risk reduction program that included addiction management treatment, according to a new study presented this week at the Association of Academic Physiatrists Annual Meeting in Orlando.
Approximately one-quarter of patients who are prescribed opioids for chronic pain misuse them, with five to 10 percent developing an opioid use disorder or addiction. In a new study, UC San Diego researchers found that opioid dependence produced permanent changes in the brains of rats.